NCT00002539: Combination Chemotherapy and Surgery With or Without G-CSF in Treating Patients With Osteosarcoma |
|
|
| Completed | 3 | 214 | Europe, RoW | filgrastim, cisplatin, doxorubicin hydrochloride, conventional surgery | European Organisation for Research and Treatment of Cancer - EORTC, Medical Research Council | Sarcoma | 10/02 | | | |
NCT00003937: Combination Chemotherapy Plus Dexrazoxane in Treating Patients With Newly Diagnosed Nonmetastatic Osteosarcoma |
|
|
| Completed | 3 | 253 | US, Canada, Europe, RoW | cisplatin, Cis-diamminedichloroplatinum II, CDDP, Platinol, NSC #119875, dexrazoxane hydrochloride, ADR-529, ZINECARD, ICRF-187, NSC #169780, doxorubicin hydrochloride, Adriamycin, NSC #123127, etoposide, VP-16, VePesid, NSC #141540, ifosfamide, IFX, IFOS, NSC #109724, methotrexate, MTX, amethopterin, NSC #000740, conventional surgery | Children's Oncology Group, National Cancer Institute (NCI) | Cardiac Toxicity, Sarcoma | 03/04 | 06/08 | | |
NCT00002546: Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Cancer of the Uterus |
|
|
| Completed | 3 | 216 | US, RoW | cisplatin, ifosfamide, adjuvant therapy, radiation therapy | Gynecologic Oncology Group, National Cancer Institute (NCI), Eastern Cooperative Oncology Group | Sarcoma | 09/07 | | | |
